|
1）Izuhara K, Arima K, Kanaji S, et al. IL-13: a promising therapeutic target for bronchial asthma. Curr Med Chem. 2006; 13: 2291-8
|
|
|
|
2）Yuyama N, Davies DE, Akaiwa M, et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine. 2002; 19: 287-96
|
|
|
|
|
|
3）Takayama G, Arima K, Kanaji T, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006; 118: 98-104
|
|
|
|
|
|
4）Sehra S, Yao W, Nguyen ET, et al. Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol. 2011; 186: 4959-66
|
|
|
|
|
|
5）Gordon ED, Sidhu SS, Wang ZE, et al. A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2012; 42: 144-55
|
|
|
|
|
|
6）Blanchard C, Mingler MK, McBride M, et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008; 1: 289-96
|
|
|
|
|
|
7）Bentley JK, Chen V, Hong JY, et al. Periostin is required for maximal airways inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. in press
|
|
|
|
|
|
8）Kanemitsu Y, Ito I, Niimi A, et al. Osteopontin and periostin associate with a 20-year decline of pulmonary function in asthmatics. Am J Respir Crit Care Med. 2014; 190: 470-4
|
|
|
|
|
|
9）Conway SJ, Izuhara K, Kudo Y, et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014; 71: 1279-88
|
|
|
|
|
|
10）Izuhara K, Arima K, Ohta S, et al. Periostin in allergic inflammation. Allergology Int. 2014; 63: 143-51
|
|
|
|
|
11）Masuoka M, Shiraishi H, Ohta S, et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 2012; 122: 2590-600
|
|
|
|
|
|
12）Uchida M, Shiraishi H, Ohta S, et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012; 46: 677-86
|
|
|
|
|
|
13）Okamoto M, Hoshino T, Kitasato Y, et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J. 2011; 37: 1119-27
|
|
|
|
|
|
14）Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011; 365: 1088-98
|
|
|
|
|
|
15）Hanania NA, Wenzel S, Rosen K, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013; 187: 804-11
|
|
|
|
|
|
16）Kanemitsu Y, Matsumoto H, Izuhara K, et al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol. 2013; 132: 305-12
|
|
|
|
|
|
17）Nagasaki T, Matsumoto H, Kanemitsu Y, et al. Integrating longitudinal on pulmonary function and inflammation using asthma phenotypes. J Allergy Clin Immunol. 2014; 133: 1474-7
|
|
|
|
|